CasNo.532-32-1,Sodium benzoate 99% high quality factory,(532-32-1) Suppliers

1 Kilogram	FOB Price:USD 10.0000 -22.0000

Min.Order :1 Kilogram
Purity: 99.0%min
Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other

Keywords

532-32-1 Sodium benzoate Sodium benzoate high purity

Quick Details

Appearance:White powder
Application:API
PackAge:25KG/drum, or according to your requirement
ProductionCapacity:20|Metric Ton|Month
Storage:Keep in dark place, Inert atmosphere, Room temperature
Transportation:by air/ sea/ express

Superiority:

Product name	Sodium benzoate
CAS number	532-32-1
Assay	≥98%
Appearance	White crystalline powder
Capacity	200mt/year
Application	Mainly used as food preservative, also used in pharmaceutical, dye and so on
More information	Synonyms: Benzoic acid sodium salt Molecular Formula: C7H5NaO2 Molecular Weight: 144.10 CAS Registry Number: 532-32-1 EINECS: 208-534-8 FEMA: 3025 Melting point: 300ºC Water solubility: soluble

Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou, Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.
In 2008, We passed ISO quality system certificate
In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.
In 2016, obtain a registered trademark “ BJM ”.
In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.
In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.
In 2020, we registered BJM Pharm Yunmeng Co., Ltd, and the new production base settled in Geputan chemical park with a total area of 50000 square meters.

We are specialized in the R&D, production and sales of Erdosteine, Pirfenidone, Telmisartan, Letrozole, Sitagliptin phosphate, Dapagliflozin, Tris, IPTG and related intermediates.
We stick to the principle as: people-oriented, customer first. Hope to establish a win-win business relationship with all friends.

Details:

Wuhan BJM Pharm Inc. established stable and reliable long-term cooperative relations with hundreds of domestic chemical factories. Through unremitting efforts, our products have exported to North America, Europe, Southeast Asia, etc., and have established long-term business relationship with customers all over the world.

Our company stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends.

● Centralized customer service supports simplification of administrative procedures, resulting in time and cost saving.
● Our Chinese network and sophisticated logistics solutions ensure that chemicals of identical quality are supplied to customers with several manufacturing locations and contribute to security in planning and reliability of processes.
● Our processes are continuously optimized and adapted to our customers’ changing structures and requirements.